BA3071

· BioAtla, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BA3071, covering 2025-06-15 to 2025-06-15. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1/2 Study of BA3071 in Patients With Solid Tumors [Phase 1, Phase 2]